Sign In
Buy BSGM
$6.10
+0 (+0%)
At Close: Dec 10, 2025
BioSig Latest Installation Broadens Clinical Footprint for its Signal Processing Technology for Electrophysiology
02:30pm, Tuesday, 13'th Jul 2021
Texas installation builds as company adds team members to support installations around major metropolitan areas Texas installation builds as company adds team members to support installations around m
BioSig to Host Conference Call to Unblind Clinical Data Collected with its Signal Processing Technology for Arrhythmia Care
10:30am, Monday, 12'th Jul 2021
Westport, CT, July 12, 2021 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (Nasdaq: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing an innovative signal proce
BioSig Announces Closing of Public Offering of Common Stock
04:10pm, Wednesday, 07'th Jul 2021
Westport, CT, July 07, 2021 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (Nasdaq: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing an innovative biomedical sign
BioSig installs PURE EP system at New York hospital as part of northeast commercial launch
11:13am, Wednesday, 07'th Jul 2021
BioSig Technologies Inc (NASDAQ:BSGM) announced that it has installed its PURE EP ECG signal processing platform system at New York-Presbyterian/Weill Cornell Medical Center in New York. Weill Cornell
BioSig Enters the New York Market with Its Signal Processing Technology for Electrophysiology
09:36am, Wednesday, 07'th Jul 2021
The Company installs its novel medical technology platform for arrhythmia care in a leading Center of Excellence The Company installs its novel medical technology platform for arrhythmia care in a lea
Mayo Clinic Purchases BioSig's PURE EP™ for use at its Phoenix Location
09:44am, Tuesday, 06'th Jul 2021
According to a recently filed 8-k, BioSig Technologies, Inc. (NASDAQ: BSGM) received a new purchase order from the Mayo Foundation for medical education and research. The institution commenced the eva
BioSig Technologies Raises $10M Via Equity Issued At $4/Share
09:37am, Friday, 02'nd Jul 2021
BioSig Technologies Inc (NASDAQ: BSGM) has priced its previously announced underwritten public offering of 2.5 million shares at $4.00 per share, representing a discount of 8% from the last close pr
BioSig announces pricing of its $10M offering of common stock
09:15am, Friday, 02'nd Jul 2021
BioSig Technologies Inc (NASDAQ:BSGM) has announced the pricing of its underwritten public offering to raise about $10 million. In a statement, the company said it could gain roughly an additional $
BioSig Announces Pricing of Public Offering of Common Stock
08:15am, Friday, 02'nd Jul 2021
Westport, CT, July 02, 2021 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (Nasdaq: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing an innovative biomedical sign
BioSig Announces Proposed Public Offering of Common Stock
04:05pm, Thursday, 01'st Jul 2021
Westport, CT, July 01, 2021 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (Nasdaq: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing an innovative biomedical s
BioSig Completes 1,000 Patient Cases and Expects 1,500 more at the end of 2021
01:36pm, Wednesday, 30'th Jun 2021
According to recent reports, the global electroceuticals/bioelectric medicine market is currently worth $16.8 billion and is projected to reach $21.5 billion by 2026, at a compound annual growth rate
BioSig says physicians have completed 1,000 patient cases with its PURE EP system technology across nine US installation sites
10:21am, Wednesday, 30'th Jun 2021
BioSig Technologies Inc (NASDAQ:BSGM) has announced that physicians have completed 1,000 patient cases with its technology across nine installation sites. The company's non-invasive computerized techn
BioSig Completes 1000 Patient Cases with its Signal Processing System for Electrophysiology
10:03am, Wednesday, 30'th Jun 2021
The Company recently increased its procedural volume targets due to accelerated technology usage BioSig expands its commercial team to target technology adoption across three strategic regions
BioSig Completes 1000 Patient Cases with its Signal Processing System for Electrophysiology
09:53am, Wednesday, 30'th Jun 2021
The Company recently increased its procedural volume targets due to accelerated technology usage BioSig expands its commercial team to target technology adoption across three strategic regions
BioSig Completes 1000 Patient Cases with its Signal Processing System for Electrophysiology
09:35am, Wednesday, 30'th Jun 2021
Westport, CT, June 30, 2021 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing an innovative biomedical s
